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Carotene, we have utilized the availability of UCP1(−/−) mice to examine a wide range of
previously proposed lipid activators of Uncoupling Protein 1 (UCP1) in its native environment, i.e. in the
brown-fat cells. A non-metabolizable fatty acid analogue, β,β¢-methyl-substituted hexadecane α,ω-
dicarboxylic acid (Medica-16) is a potent UCP1 (re)activator in brown-fat cells, despite its bipolar structure.
All-trans-retinoic acid activates UCP1 within cells, whereas β-carotene only does so after metabolism. The
UCP1-dependent effects of fatty acids are positively correlated with their chain length. Medium-chain fatty
acids are potent UCP1 activators in cells, despite their lack of protonophoric properties in mitochondrial
membranes. Thus, neither the ability to be metabolized nor an innate uncoupling/protonophoric ability is a
necessary property of UCP1 activators within brown-fat cells.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
To better understand the regulation of UCP1 activity within intact
brown-fat cells, we examine here the uncoupling properties of fatty
acids and fatty acid analogues when they are added to isolated brown-
fat cells. To identify the UCP1-dependent component of the thermo-
genic response,weutilize brown-fat cells isolated frombothUCP1(−/−)
andwild-type animals and compare the results. The experiments have
been designed based on results obtained with brown-fat mitochon-
dria, and the basic question is to what degree the outcome from
mitochondrial experiments can be extended to cells, considering the
different environment UCP1 experiences under these conditions and
especially the possibility that the fatty acids may be speciﬁcally
metabolized in the cellular system. It may also be noted that for
possible treatment of obesity through UCP1 activation, it would be
advantageous that a candidate substance is not in itself a substrate for
oxidation, but rather it should be a good UCP1 activator, stimulating
combustion of endogenous substrate. It is therefore of importance to
be able to distinguish substrate and uncoupling properties of
suggested UCP1-activating agents in an intact cellular system.8 156756.
ll rights reserved.1.1. Regulation of UCP1 activity in brown-fat mitochondria
In brown-fat mitochondria, the activity of UCP1 is tightly regulated
(for general overviews see e.g. [1,2]). Mainly from studies of isolated
brown-fat mitochondria, several hypotheses concerning the regula-
tion of Uncoupling Protein 1 (UCP1) activity have been suggested,
mainly pointing to fatty acids as (re)activators. Thus, in isolated brown-
fat mitochondria, purine nucleotides (experimentally routinely GDP)
bind to UCP1 from the cytosolic side and inhibit the spontaneous
proton transport activity of UCP1. In isolated brown-fat mitochondria,
fatty acids can overcome this nucleotide inhibition in a functionally
competitive way and thus increase the proton conductance [3]. It has
been discussed whether UCP1 activation is dependent on fatty acid
structure [4,5], their ability toﬂip-ﬂop [6,7], their level of saturation [8]
and/or the chain length of the fatty acids [9–11]. Mitochondrial studies
of fatty acid effects on UCP1 are routinely performed under conditions
where fatty acid metabolism does not occur, and the issue whether
their metabolism can affect the results has therefore only been
addressed to a limited extent.
Until recently, the analysis of the effects of fatty acids on UCP1 in
brown-fatmitochondriawas hampered bywhatwe refer to here as the
qinnate uncoupling effectsq of fatty acids, i.e. the ability of most fatty
acids to induce uncoupling (i.e. to increase basal (state 4) respiration)
in different types of mitochondria [12] that do not contain UCP1.
The mechanism behind innate uncoupling is unclariﬁed, but the
Fig. 1. Fatty acid-induced oxygen consumption in brown-fat cells does not require fatty acid metabolism. Oxygen electrode traces of 100000 brown-fat cells from UCP1(+/+) mice
examined in the absence (A, C, E) or presence (B, D, F) of 5 mMpyruvate. Further additions were 40 µM FCCP (the high concentration, as also for the fatty acids, is necessary because of
the 4% albumin that is present), 2 mM palmitate or 2 mM Medica-16. A and B were redrawn from data earlier published in [5].
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nated fatty acids enter the mitochondria uncatalysed through the
mitochondrial membrane (the ﬂip-ﬂop pathway) and are expelled in
the anionic form through different mitochondrial carriers, thus
essentially being shuttled carryingprotonsback into themitochondrial
matrix. Thus, in this hypothesis, to be an innate uncoupler, a fatty acid
(analogue) also has to be a ﬂip-ﬂopable substance. This cycling
mechanism was extended by Skulachev/Garlid/Jezek [15–17] to also
apply to UCP1, by this explaining the (apparent) protonpermeability of
UCP1. It is thus the prediction of this hypothesis that a UCP1 activator
must also be an innate uncoupler and is thus ﬂip-ﬂopable.
Until recently, it was thus not possible to distinguish whether
uncoupling caused by a given fatty acidwas due to its innate uncoupling
property or due to UCP1 activation. However, the availability of brown-
fat mitochondria from UCP1(−/−) mice has enabled distinction between
UCP1-dependent and UCP1-independent effects of fatty acids on
brown-fat mitochondria [3].In addition to fatty acids, and fatty acid-like compounds, several
other activators of UCP1 have been suggested and discussed. These
include superoxide [18–20] and 4-hydroxy-nonenal [21,22,20].
1.2. UCP1 regulation in brown-fat cells
Regulation of UCP1 within brown-fat cells has been examined much
less than its regulation inmitochondria. It is generally believed thatwithin
the cells, when the cells are not stimulated, UCP1 activity is inhibited by
cytosolic purine nucleotides, i.e. primarily ATP (similarly to GDP in routine
experiments with isolated mitochondria). It may therefore be said that
UCP1 has to become re-activated for thermogenesis to occur. Physiologi-
cally, thermogenesis is stimulated by norepinephrine, and it is generally
believed that it is through norepinephrine-induced lipolysis and the
resulting release of fatty acids within the cell that UCP1 inhibition is
overcome. Indeed, in isolated brown-fat cells, addition of fatty acids leads
to thermogenesis that is UCP1-dependent [5].
644 I.G. Shabalina et al. / Biochimica et Biophysica Acta 1777 (2008) 642–650However, in many ways, the situation in the cell is different from
that in isolated mitochondria. The medium surrounding UCP1 and the
mitochondria in general is muchmore complex than themediumused
in mitochondrial experiments. The cytosolic fatty acid buffer is not the
experimentally used albumin – which is a serum protein – but pre-
sumably different fatty acid binding proteins, both the adipocyte-
speciﬁc fatty acid binding protein A-FABP (often referred to as qaP2q)
and the heart-speciﬁc version of this protein H-FABP [23]. Importantly,
in the cell, the fatty acids released from the stored triglycerides will be
metabolized, and this metabolism produces different metabolites,
some of which may be physiological regulators of UCP1 activity.
Correspondingly, compounds that are inactive in the mitochondrial
systemmaybecomemetabolized into active compounds in the cellular
system.
Here we utilized brown-fat cells isolated from UCP1(−/−) mice versus
brown-fat cells from wild-type mice (i.e. UCP1-containing cells) to
establish UCP1 involvement in the thermogenic response to a range of
fattyacid(-like) compounds.Wehaveparticularlyexamined their ability to
activate UCP1 without themselves being substrates for thermogenesis.
2. Materials and methods
2.1. Animals
Themice used in the experiments were UCP1(−/−) and UCP1(+/+) mice on a C57Bl/6
genetic background (progeny of the UCP1(−/−) mice described in [24] were backcrossed
to C57Bl/6 for 10 generations and were after inter-cross maintained as an inbred strain
for a further 4–5 generations). The mice were fed ad libitum (R70 Standard Diet,
Lactamin), had free access to water, and were kept on a 12:12 h light:dark cycle. No
differences in normal growth were detected between the UCP1(−/−) and UCP1(+/+)
strains at normal (24 °C) animal house temperature. Adult (8–12-week old) male mice
were used for the experiments. The experiments were approved by the Animal Ethics
Committee of the North Stockholm region.
2.2. Brown-fat cells
Mouse brown-fat cells were isolated as earlier described by collagenase digestion of
pooled brown adipose tissue depots [5]. Routinely, on each experimental day, 6–8 wild-
type mice or 5 UCP1(−/−) mice were killed by CO2 anesthesia and decapitated. The
interscapular, cervical, and axillary brown adipose tissue depots were cleaned from
contaminating muscle and white adipose tissue and placed in Krebs–Ringer phosphate
buffer containing 4% crude bovine serum albumin (see “Buffers”). This buffer was
changed to 3ml with 1.3 mg/ml collagenase II (Sigma), and the tissuewas incubated in a
slowly shaking water bath at 37 °C with vortexing every second min. After 7 min, the
buffer was discarded, and the tissue was placed in 6 ml of fresh buffer with 0.67 mg/ml
collagenase II, minced with scissors, and incubated for 45 min in the water bath,
vortexing every 5 min. The buffer with cells and tissue fragments was ﬁltered through
silk cloth, and the ﬁltrate, containing the adipocytes, was centrifuged for 8 min at 30 ×g.
The infranatant was discarded and fresh buffer was added. The remaining tissue was
incubated another 30–45 min in 3 ml of buffer with 0.33 mg/ml collagenase, vortexed
every 5 min, and collected. The two cell suspensions were pooled and washed by
ﬂoating for 1 h. The buffer was removed, and the concentrated cell suspension, 1–4×106
cells/ml, was counted in a Burker chamber and divided into aliquots that were kept at
room temperature during the day of the experiment.
2.3. Cellular oxygen consumption
Oxygen consumption rates of the isolated brown-fat cells were monitored with a
Clark-type oxygen electrode, as described previously [25]. 100000 cells were added to a
magnetically stirred oxygen electrode chamber thermostated at 37 °C, containing
Krebs–Ringer bicarbonate buffer (see “Buffers”) to a ﬁnal volume of 1.1 ml. The chamber
was closed, and the cells were incubated. The basal rate of oxygen consumption was
determined and additions (as indicated) were made with Hamilton syringes through a
small hole in the cover of the oxygen electrode chamber. Each type of experiment was
performed in several cell preparations, on different days. Every cell preparation was
tested with norepinephrine before the actual experiment was performed. For
calculations, distilled water was considered to contain 217 nmol O2/ml at 37 °C. The
output signal from the oxygen electrode ampliﬁer was collected every 0.5 s by a
PowerLab/ADInstrument (application program Chart v5.1.1.).
2.4. Buffers
Krebs–Ringer phosphate buffer (used for cell preparation and storage only) had the
following composition: 148mMNa+, 6.9 mM K+,1.5 mM Ca2+, 1.4 mMMg2+, 119 mM Cl−,
1.4 mM SO42−, 5.6 mMH2PO4−, 16.7 mM HPO42−, 10 mM glucose, and 10 mM fructose, with
4% crude bovine serum albumin. The pHwas adjustedwith Tris–OH to 7.4. Krebs–Ringerbicarbonate buffer (used for all cellular experiments) had the following composition:
145mMNa+, 6.0 mMK+, 2.5 mM Ca2+,1.2 mMMg2+,128mMCl−, 1.2mM SO42−, 25.3 mM
HCO3−, 1.2mMH2PO4−, 10mMglucose, and 10mM fructose, with 4% fatty acid-free bovine
serum albumin. This buffer was purchased as a sterile solution from SVA, Uppsala,
Sweden. The buffer was bubbled with 5% CO2 in air, and the pHwas adjustedwith HCl to
7.4; the buffer was continuously bubbled at 37 °C with a small stream of 5% CO2 in air
until use.
2.5. Chemicals
Fatty acid-free bovine serum albumin, fraction V, was from Boehringer Mannheim.
Norepinephrine, FCCP (carbonyl cyanide p-(triﬂuoromethoxy)phenylhydrazone), pyru-
vic acid (sodium salt), palmitic acid (C 16:0) and all-trans-retinoic acid were all from
Sigma-Aldrich. Propionic (C 3:0) acid, caproic (hexanoic, C 6:0) acid and caprylic
(octanoic, C 8:0) acid were from Fluka Chemie. β,β′-methyl-substituted hexadecane
α,ω-dicarboxylic acid (Medica-16) was synthesized as previously described [26].
β-Carotene was a gift from Roche (Switzerland). FCCP was dissolved in 50% ethanol.
Palmitic acid was dissolved in 96% ethanol. Caproic and caprylic acids were dissolved in
70% ethanol and then diluted with 20 mM K-Tes (pH 7.2) to approximately 10–20%
ethanol, and the solutionwas then readjusted to pH7.2. Ethanol in aﬁnal concentration of
0.1% did not in itself have any effects on the parameters measured. Norepinephrine was
dissolved and diluted in water, freshly prepared for each experiment. All-trans-retinoic
acidwasdissolved anddiluted inMe2SO,which in aﬁnal concentration of 0.05% did not in
itself have any effect on the parameters measured. β-Carotene was dissolved in
tetrahydrofuran (according to a recommendation from Roche (Switzerland)), and control
experiments on the effect of solvent were performed.
3. Results and discussion
In unstimulated isolated brown-fat cells, the mitochondria are in a
coupled state (despite the presence of UCP1) and there is low avai-
lability of endogenous substrate. The coupled state is e.g. evident from
our earlier observations (reproduced in Fig.1A and B) that the presence
of extra, easily catabolized, substrate in the form of pyruvate does not
in itself lead to increased rates of oxygen consumption (qthermo-
genesisq) (compare ﬁrst parts of Fig. 1A and B), and from the fact that
the rate is increased after the addition of the artiﬁcial uncoupler FCCP.
As the FCCP-induced increase ismuch higherwhenpyruvate is present
in themedium (second part of Fig.1B versus second part of Fig.1A), the
magnitude of the uncoupled thermogenesis is limited by the
availability of endogenous substrate [5].
In the present study,we have used this ability of pyruvate to function
as an easily catabolizable substrate, together with the availability of
brown-fat cells from UCP1(+/+) and UCP1(−/−) mice, to examine
questionswhether different fatty acid (analogues) in the cellular system
need to be metabolized to induce activation of thermogenesis and
whether any uncoupling that is observed is mediated by UCP1 rather
than being a reﬂection of an innate uncoupling effect of these agents on
the mitochondria.
3.1. The non-metabolizable fatty acid analogue Medica-16 is a potent
UCP1 activator in brown-fat cells
The fatty acid analogue Medica-16 is a β,β¢-methyl-substituted
hexadecanedioic acid. It was developed to be used as tool to dis-
tinguish between catabolism-dependent and -independent effects of
fatty acids. This is based on the fact that the methyl groups on the
β-carbons make β-oxidation impossible. Medica-16 may, however, be
thioesteriﬁed into theMedica-16-CoA thioester by the long-chain fatty
acyl-CoA synthetase [27,28]; the reactivity of its carboxyl group is thus
not severely affected by the extra methyl groups. It is likely that
Medica-16-CoA may be transacylated into Medica-16-carnitine which
may be able to enter mitochondria and there become transacylated
back into Medica-16-CoA, but entry into β-oxidation is, as indicated,
not chemically possible. Based on its inability to undergo β-oxidation,
Medica-16 has e.g. been used to distinguish between substrate effects
and uncoupling effects of long-chain fatty acids in oxidative phos-
phorylation [29]. Similarly, by comparing the effects of palmitate (a
metabolizable fatty acid of the same chain length) and Medica-16 on
thermogenesis in brown-fat cells, we have examined whether fatty
acid metabolism beyond the acyl-CoA/acyl-carnitine stage is required
Fig. 2. Medica-16-induced oxygen consumption is mainly mediated via activation of UCP1. A, B, Representative traces showing the effects of Medica-16 on oxygen consumption in
brown-fat cells isolated from UCP1(−/−) (A) or UCP1(+/+) (B) mice. Additions were as in Fig. 1. C, Compilation of the effect of Medica-16 and palmitate in brown-fat cells isolated from
UCP1(+/+) (ﬁlled symbols) or UCP1(−/−) (open symbols) mice. Only the fatty acid-stimulated respiration is shown. The points are means±S.E. of 3 independent cell preparations for
each group, examined in the presence of pyruvate principally as in A and B. D, The UCP1-dependent part of theMedica-16 and palmitate-induced stimulation of oxygen consumption.
Data were obtained by subtracting the UCP1(−/−) values from the corresponding UCP1(+/+) values in C.
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earlier veriﬁed that Medica-16, similarly to palmitate, can reactivate
UCP1 in isolated brown-fat mitochondria (not shown).
3.1.1. Medica-16 is not a substrate for thermogenesis
Fig. 1C demonstrates that the addition of palmitate (C 16:0) to
brown-fat cells in itself causes thermogenesis even in the absence of an
easilymetabolizable substrate in themedium, as has earlier been shown
fordifferent long-chain fattyacids (e.g. [30,11,5]. In the trace shownhere,
a further addition of the same amount of palmitate induced a higher
level of thermogenesis. This rate could only marginally be further
stimulated by the artiﬁcial uncoupler FCCP, but the resulting level was
muchhigher than that seenafter the addition of FCCPdirectly to the cells
(Fig. 1A). Thus, palmitate not only uncoupled the cellular respiration (as
did FCCP) but was also catabolized by the cell to make it the main
substrate of this thermogenesis.
When a similar experiment was performed in the presence of
pyruvate (Fig. 1D), the response was similar but augmented, implying
that the uncoupled mitochondria within the cells utilized both the
palmitate and the pyruvate simultaneously as substrate.
These observations may be contrasted with those seen after the
addition of Medica-16 instead of palmitate (Fig. 1E). In the absence of
pyruvate, a small increase in thermogenesis was seen, similar to that
observed after FCCP alone (Fig. 1A), but further additions of Medica-16
werewithout further effect, and FCCP did not further increase the rate.
Thus, it would seem that Medica-16 could uncouple, but as the rate
was not higher than that seen after addition of FCCP, Medica-16 was
not in itself a substrate for thermogenesis in brown-fat cells.
In the presence of pyruvate, Medica-16 had a very marked ther-
mogenic effect that was further enhanced with a second addition ofMedica-16. Further addition of FCCP did not further increase the rate,
which again was the same as when FCCP was directly added to the
cells in the presence of pyruvate (Fig. 1B). Thus, Medica-16 was as
competent as FCCP in uncoupling the mitochondria within the cells,
but, as expected, it could not serve as substrate for oxidation in
mitochondria within brown-fat cells. Similar observations have been
observed in other type of cells [29].
3.1.2. Medica-16-induced uncoupling is composed of both UCP1-
independent and UCP1-dependent components
To investigate whether the uncoupling effect of Medica-16 was
mediated by UCP1 or reﬂected an innate uncoupling effect of Medica-
16, similar experiments (in the presence of pyruvate) were performed
in brown-fat cells that lacked UCP1 (Fig. 2). Even in the brown-fat cells
without UCP1, a stimulatory effect of Medica-16 could be seen after
several additions (Fig. 2A). Thus, this would indicate that the Medica-
16 effect observed represented an innate uncoupling effect of fatty
acid (analogues) on the mitochondriawithin the cells. However, when
the experiment was repeated in wild-type (i.e. UCP1-containing)
brown-fat cells (Fig. 2B), the effect was markedly higher, indicating
that at least a substantial fraction of the Medica-16 uncoupling effect
in wild-type brown-fat cells was mediated by UCP1.
Fig. 2C compiles data obtained when different cell preparations
were examinedwithMedica-16 (as in Fig. 2A and B) and similarly with
palmitate. The two lower lines (open symbols) represent data from
brown-fat cells from UCP1(−/−) mice. It is seen that palmitate in high
doses does have a stimulatory qthermogenicq effect, even in the
absence of UCP1 (as has been observed in other cell types [31–34] ). In
the cells from UCP1(−/−) mice, the effect of Medica-16 is very similar
to that of palmitate.
Fig. 3. All-trans-retinoic acid and β-carotene effects in brown-fat cells. A, B, C, D, Representative traces showing the effects of all-trans-retinoic acid on oxygen consumption in brown-
fat cells isolated from UCP1(−/−) (A, C) or UCP1(+/+) (B, D) mice. Additions were 100000 cells, 5 mM pyruvate (C, D) and 40 µM FCCP (A, C) or 1 µM norepinephrine (NE) (B, D). All-
trans-retinoic acid additions were 2 mM (A), 2 mM (B), 2×1 mM (C) or 0.5 mM (D). E, The UCP1-dependent part of the retinoic acid and palmitate-induced stimulation of oxygen
consumptionwere obtained by subtracting the rates observedwith UCP1(−/−) cells from those observedwith (UCP1(+/+) cells (underlying data not shown). For all-trans-retinoic acid,
the corresponding values were principally obtained as in C and D; experiments were repeated twice with 1–2 independent cell preparations for each group. For palmitic acid, values
are as in Fig. 2. F, The effect of tetrahydrofuran (solvent) and β-carotene (0.25 mM) on brown-fat cells. G, Effect of carotene addition on brown-fat cells during a prolonged incubation.
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remarkable, as Medica-16 is a dual-carboxyl fatty acid that theoreti-
cally not should be able to easily ﬂip-ﬂop over the mitochondrialmembrane, and as ﬂip-ﬂopability should be a necessary property of
fatty acid (analogues) that can carry out innate uncoupling according
to the Skulachev/Garlid cycling mechanism [13,14]. However,
647I.G. Shabalina et al. / Biochimica et Biophysica Acta 1777 (2008) 642–650unexpectedly, Medica-16 is experimentally a ﬂip-ﬂopable substance
[35], and it has also earlier been demonstrated to induce a decrease in
membrane potential in isolated liver mitochondria and cells, accom-
panied by an increase in mitochondrial respiration [29], an effect that
might be mediated by the ATP/ADP-antiporter [29] (in accordance
with it participating in a Skulachev/Garlid cycling mechanism) or by
permeability transition in the presence of Ca2+ [36] (Samovski,
Kalderon and Bar-Tana, in prep.). Thus, the ability of both palmitate
and Medica-16 to induce uncoupling in UCP1(−/−) cells implies that
they are both innate uncouplers.
In brown-fat cells from UCP1(+/+) mice (Fig. 2C, upper lines, ﬁlled
symbols), the response to palmitate is much higher than that in UCP1
(−/−) cells, demonstrating that palmitate-induced thermogenesis (just
as oleate- (18:1) and laurate-induced thermogenesis (12:0) [5]) is
truely UCP1-dependent. The compilation also demonstrates that the
Medica-16 effect is much higher in brown-fat cells with UCP1, i.e
Medica-16 does activate UCP1 as does palmitate, despite the fact that
Medica-16 is not metabolizable.
For both palmitate and Medica-16, the UCP1-dependent effect was
calculated as the difference between the UCP1(+/+) and the UCP1(−/−)
values and the outcome is shown in Fig. 2D. It is noteworthy that at
higher concentrations, palmitate stimulates thermogenesis more than
does the equivalent amount of Medica-16. It is reasonable to assume
that this extra increase results from the fact that palmitate also
functions as a substrate. It is also noteworthy that this difference is not
seen at low palmitate/Medica-16 concentrations where UCP1-depen-
dent thermogenesis is already seen. Thus, it can be deduced that
although palmitate in the cell can both function as an activator of
UCP1 and as a substrate for thermogenesis, the level required for
stimulation of UCP1 may be lower than that where it can be used as
substrate.
Taken together, these experiments with Medica-16 principally
demonstrate thatmetabolism of a fatty acid is not necessary to allow it
to function as a UCP1 activator within the brown-fat cell. However, it
should be remembered that the methylation of the β,β¢-carbons only
means that β-oxidation cannot proceed. The ﬁrst step in fatty acid
catabolism, i.e. the activation of the fatty acid that acyl-CoAs are not
affected. Indeed, the intracellular acyl-CoA proﬁle of cells exposed to
Medica-16 is dominated by Medica-16-CoA [28]. Thus the Medica-16
studies do not in themselves allow us to conclude that Medica-16-CoA
is not involved in the control of UCP1 in the cellular system, as has
indeed been suggested and discussed [37–42,5]. The ability of the CoA
ester of palmitate to compete for purine nucleotides in isolated UCP1
is more than 10-fold higher than that of palmitate itself [10].
Medica-16 has been used in the treatment of an animal model for
obesity-induced insulin resistance [43,44], and different pathways for
this effect were suggested. The results presented here indicate that the
anti-obesity effect of Medica-16 could also result from an activation of
UCP1, a possibility that would require further study.
3.2. All-trans-retinoic acid: a non-metabolizable, UCP1-activating fatty
acid analogue that does not induce innate uncoupling
Similarly to Medica-16, all-trans-retinoic acid (referred to below as
retinoic acid) is a fatty acid-like compound. Retinoic acid has been
examined in control of body energy balance [45] and has been
demonstrated to be a competent activator of UCP1 in isolated brown-
fat mitochondria [4], in yeast with expressed UCP1 [46] and in brown
adipocytes [5]. We have conﬁrmed that retinoic acid can reacti-
vate UCP1 in GDP-inhibited brown-fat mitochondria (not shown, in
agreement with [4]). Similarly to what is the case for Medica-16,
retinoic acid can be metabolized to its CoA ester retinoyl-CoA [47]
but the β-carbon is blocked by a methyl group, which means that
β-oxidation cannot proceed. We therefore analysed the effect of
retinoic acid, principally following the same scheme as that used above
for Medica-16.In the absence of the easily oxidizable substrate pyruvate, retinoic
acid had no stimulatory effect on oxygen consumption in brown-fat
cells isolated from UCP1(−/−) mice (Fig. 3A). The cells afterwards
responded to FCCP with a similar increase in rate as that observed
when no retinoic acid had been added (cf. Fig. 1A). This indicates that
retinoic acid could not serve as substrate for cellular oxidation. In UCP1
(+/+) cells, retinoic acid exhibited a thermogenic effect, but the
magnitude was small (Fig. 3B). This indicates that retinoic acid can
activate UCP1 within the brown-fat cells but that the thermogenesis
observed is limited by the small amount of endogenous substrate; this
conclusion is principally conﬁrmed by the large response to norepi-
nephrine (which generates substrate — see above) that can be
observed even after retinoic acid addition.
Not even the presence of extra substrate for oxidation (pyruvate)
enabled any uncoupling effect of retinoic acid to be observed in UCP1(−/−)
brown adipocytes (Fig. 3C), indicating that retinoic acid has no innate
uncoupling properties. This is in contrast towhatwas the case concerning
the fatty acid analogue Medica-16 (Fig. 2A), which, similarly to retinoic
acid, couldnot itself beoxidized (Fig.1) but coulduncouple cells in aUCP1-
independent manner (Fig. 2C). The presence of substrate for oxidation
(pyruvate)dramatically increased the thermogenic effectof retinoic acid in
UCP1(+/+) brown adipocytes (Fig. 3D), clearly conﬁrming its ability to
function as an efﬁcient UCP1 activator in the brown-fat cell system.
In both UCP1(−/−) and UCP1(+/+) cells, the effects of retinoic acid
were tested using different concentrations (not shown), and the UCP1-
dependent effectwas calculatedby subtraction of the effect inUCP1(−/−)
cells from that in UCP1(+/+) cells (Fig. 3E). A comparison of the UCP1-
dependent retinoic acid and palmitate responses revealed that retinoic
acidmaximally activatedUCP1 at an at least 10-fold lower concentration
thandid palmitic acid (Fig. 3E). This difference in sensitivitycould bedue
to differences in afﬁnities to albumin between retinoic and palmitate.
Retinoic acid has lower afﬁnity for albumin than thas palmitate [48,49],
leading to higher concentrations of the free compound for the same
nominal addition. A true higher sensitivity of UCP1 for retinoic acid than
for palmitate can, however, not be excluded.
Taken together these experiments point to retinoic acid as an
interesting experimental tool for cell studies, combining high afﬁnity
as an activator of UCP1 with no innate uncoupling activity and an
inability to become metabolized.
3.3. Carotene as a potential UCP1 activator
β-Carotene (carotene below) is a precursor of retinoic acid and
accumulates in adipose tissues [50]. Carotene can be converted
intracellularly to retinoids including retinoic acid [51], and retinoids are
also stored in adipose tissues [52]. In contrast to retinoic acid, carotene is
not in itself a UCP1 (re)activator in isolated brown-fat mitochondria (our
unpubl. obs), but it could be suggested that carotenewithin the brown-fat
cell could be metabolized to a signiﬁcant degree to retinoic acid and thus
become a UCP1 activator. We therefore examined whether carotene
showed features of becoming a UCP1 activator in the cellular system.
Carotene was dissolved in tetrahydrofuran which, in itself, did not
uncouple the brown-fat cells (Fig. 3F). Addition of the carotene slightly
increased the basal oxygen consumption of UCP1(+/+) brown adipocytes
respiring in the absence of pyruvate (Fig. 3F), as did retinoic acid (Fig. 3B).
The small stimulatoryeffect ofβ-carotene occurred only inUCP1(+/+) cells
and not in UCP1(−/−) cells (Fig. 3G). We incubated brown-fat cells with
carotene for an extended time (Fig. 3G). As seen, the stimulatory effect of
β-carotenewas time-dependent and reached amaximum after 15min of
incubation. The small and time-dependent effect of β-carotene on oxygen
consumption in UCP1(+/+) cells could be explained by successive
accumulation in the brown-fat cells of retinoic acid obtained from
carotene cleavage. Thus, these carotene effects constitute an example
where cellular metabolism converts a non-activating compound to an
activating compound. Whether dietary carotene has a brown adipose
tissue activating effect in-vivo is presently not known.
Fig. 4. Ability of fatty acids with different chain lengths to activate UCP1 within brown-fat cells. A, B, Representative traces showing the effects of palmitate (C16:0) (A) and caproate
(C6:0) (B) on oxygen consumption in brown-fat cells isolated from UCP1(−/−) (thin line) or UCP1(+/+) (thick line) mice. 5 mM pyruvate was present in the medium and further
additions were each of 2 mM palmitic acid (C16:0) or 2.7 mM caproate (C6:0) or 40 µM FCCP. C, D, Fatty acid concentration-response curves obtained in brown-fat cells isolated from
UCP1(−/−) (C) or UCP1(+/+) (D) mice. The experiments were performed principally as those illustrated in A, B. The points are means±S.E. of 3 independent cell preparations for each
group. Only the fatty acid-stimulated parts of the respiration are shown. E, The UCP1-dependent part of the fatty acid-induced stimulation of oxygen consumption; points were
obtained by subtracting the corresponding values in C from those in D. F, Dependence of UCP1-dependent effect on fatty acid chain length. Points are interpolated from E at 4 mM
nominal fatty acid concentration.
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uncouplers
Although medium-chain and long-chain fatty acids have princi-
pally the same structure, there are functional differences between
these fatty acid types. In contrast to long-chain fatty acids, medium-
chain fatty acids can be activated and thus oxidized inside the mito-
chondrial matrix (although to our knowledge this property has never
been directly demonstrated in brown-fat mitochondria). They would
therefore not accumulate in the matrix, in contrast to long-chain fatty
acids, and would therefore not need export mechanisms to avoid
lipotoxicity [53,54]. Moreover, medium-chain fatty acids do not haveprotonophoric properties [12], i.e. they are not innate uncouplers. A
study of medium-chain fatty acids as possible regulators of UCP1
activity in brown-fat cells could therefore be elucidating concerning
the mechanism of activation of UCP1 — in particular whether UCP1
functions as implied in the Skulachev/Garlid/Jezek hypothesis forUCP1
activation [15–17] where an activator of UCP1 must also have pro-
tonophoric activity (innate uncoupling).
We have therefore investigated the ability of certain medium- and
short-chain fatty acids to function as activators of UCP1. This ability
has been delineated by comparing their activation ability in brown-fat
cells isolated from UCP1(−/−) and UCP1(+/+) mice. To ensure that the
fatty acids could display their UCP1-activating potential (whether or
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ments were performed in the presence of pyruvate.
As demonstrated above, in brown-fat cells from UCP1(−/−) mice, the
long-chain fatty acid palmitate could induce an increase in oxygen
consumption (Fig. 4B, thin line), again conﬁrming the innate uncoupling
properties of long-chain fatty acids when added directly to any kind of
mitochondria [12,55] or to cell types lacking UCP1 [31–34]. The dose-
response curve for this effect of palmitate is compiled in Fig. 4C. As
expected, and inagreementwith earlierdataonoleate (C18:1) and laurate
(C 12:0) [5], the long-chain fatty acid palmitate (C 16:0) also stimulated
oxygen consumption of UCP1(+/+) brown adipocytes in a concentration-
dependent-manner (Fig. 4A) but the degree of stimulation of oxygen
consumption in the UCP1(+/+) brown-fat cells was signiﬁcantly higher
than it was in the UCP1(−/−) brown-fat cells (Fig. 4A). This indicates a
similar UCP1-dependent shift in sensitivity to fatty acid in brown-fat cells
as was earlier demonstrated for brown-fatmitochondria [3,55]. The dose-
response curve for this effect of palmitate is compiled in Fig. 4D.
In contrast to the long-chain fatty acid palmitate, the medium-
chain fatty acid caproate (hexanoate, C6:0) was without any effect in
UCP1(−/−) cells (Fig. 4B, thin line), at any concentration tested (Fig. 4E).
Despite its lack of innate uncoupling property, caproate was effective
in stimulation of oxygen consumption in UCP1(+/+) brown-fat cells
(Fig. 1B, thick line). The high response implies that it not only
functions as a UCP1 activator but is also metabolized itself; indeed the
stimulatory effect of caproate persisted independently on whether or
not pyruvate was present (not shown). The dose-response curve for
caproate in brown-fat cells from UCP1(+/+) mice is shown in Fig. 4D.
Another medium-chain fatty acid, caprylate (octanoate, C8:0) de-
monstrated patterns of oxygen consumption stimulation similar to
caproate (Fig. 4C and D). The short-chain fatty acid propionate (C3:0)
was without any effect in UCP1(−/−) cells and virtually without effect
even in UCP1(+/+) cells (Fig. 4C and D).
It is clear from the compilation in Fig. 4C that there is a principal
difference between long-chain versus medium- and short-chain fatty
acids in that an innate uncoupling effect can only be observed for
long-chain fatty acids, even in the cellular system (cf. the data of
Schönfeld et al. [56] andWojtczak and Schönfeld [12] inmitochondrial
systems).
From the compilations in Fig. 4C and D, the dose-response curves
for the ability of the different fatty acids to activate UCP1 can be drawn
(as the difference between the two curve sets); these are presented in
Fig. 4E. Three features may directly be noted. One is that although it is
not experimentally possible to increase the concentration of the fatty
acids sufﬁciently to obtain saturation of the system (as fatty acids in
higher concentrations function as detergents and destroy the cells), it
would seem by extrapolation that the inherent activation capacity of
all tested fatty acids – except for propionate – is similar and that the
difference is only in their afﬁnity. The second feature to note is that all
these UCP1-activators veriﬁed here are saturated fatty acids. This good
ability of saturated fatty acids to activate UCP1 within the brown-fat
cells is noteworthy considering the observations that (poly)unsatu-
rated fatty acids are much better than saturated for UCP1 activation in
in-vitro systems [8]. The third feature is that the fatty acids may
be good UCP1 activators irrespectively of whether they are innate
uncouplers or not; this feature is not easily compatible with the fatty
acid-cycling hypothesis for UCP1 function as discussed by Skulachev/
Garlid/Jezek [15–17].
In Fig. 4F, the UCP1-dependent effect of the different fatty acids (at
a given nominal concentration) is expressed as a function of fatty acid
chain length. The effect is remarkably linearly correlated with fatty
acid chain length. This is probably not a reﬂection of different afﬁnities
of the fatty acids for the external fatty acid buffer albumin, as this
afﬁnity would decrease with decreasing fatty acid length and the free
concentration would therefore be higher for the shorter fatty acids.
Still, the very linear correlation implies that a physical property of the
fatty acid is determinative for the activating effect.The data here may be compared with the data of Bukowiecki et al.
[11] who studied fatty acid chain length dependence of thermogenesis
in isolated rat brown-fat cells. They were obviously not able to
distinguish between UCP1-dependent and UCP1-independent (innate
uncoupling) effects, but they found the cells to be fully unresponsive
to caproate (hexanoate, C6:0), in contrast to what we see here.
At the mitochondrial level, comparisons of fatty acid effects as a
function of chain length have also been made [9]. Based on the
determination of the inhibition constants of various fatty acids for
purine nucleotide binding, Huang [10] demonstrated that short-chain
(C≤6) fatty acids display no afﬁnity, whereas medium-chain (C8–C12)
fatty acids exhibit stronger afﬁnity (but the long-chain fatty acids did
not have a stronger afﬁnity than the medium-chain ones). This means
that our data – that caproate can activate UCP1 in the cellular system –
are not fully in accordance with what could be deduced from this in-
vitro system. However, it may be pointed out that Huang demon-
strated that activation of a fatty acid may dramatically increase its
afﬁnity (palmitoyl-CoA has an afﬁnity more than 10-fold higher than
that of palmitate itself [10]). Thus, if the CoA ester is the UCP1 activator
within the cells, even caproate-CoA may be effectful.
Thus, here we demonstrated for the ﬁrst time that medium-chain
fatty acids are potent UCP1 activators within brown-fat cells, despite
their lack of protonophoric properties in mitochondrial membranes.
4. Conclusion
In the present investigation,we have utilized the availability of UCP1
(−/−) mice to establish to which extent observed thermogenic effects of
fatty acids and fatty acid analogues in brown-fat cells are mediated by
UCP1. We have examined this activating activity in UCP1's native
environment, i.e. in the mitochondria within the brown-fat cells. We
have ensured (by addition of the well-oxidized substrate pyruvate) that
UCP1 activation would be observed irrespectively of whether or not
the fatty acid (analogue) in itself was a thermogenic substrate, and we
have examined whether an innate uncoupling property is a necessity
for being an activator of UCP1, as implied by certain hypothesis for
UCP1 function. We found that a non-metabolizable fatty acid analo-
gue Medica-16 is a potent UCP1 (re)activator in brown adipocytes,
demonstrating that the ability to be metabolized is not required to be a
UCP1 activator within the brown-fat cells. Despite its bipolar structure,
Medica-16 is also an innate uncoupler in this system, and the
investigation with Medica-16 can therefore not be used to conclude
whether innate uncoupling/ﬂip-ﬂopability is a necessary property of
UCP1 activators. In contrast, all-trans-retinoic acid (that is also not a
substrate for thermogenesis) is not an innate uncoupler but is a potent
activator of UCP1 within the brown-fat cell. Similarly, medium-chain
fatty acids are potent UCP1 activators, despite the absence of
protonophoric properties in mitochondrial membranes. Thus, neither
the ability to be metabolized nor an innate uncoupling ability is a
necessary property of UCP1 activators within brown-fat cells.
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